Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Halozyme Therapeutics, Inc. HALO

Set alert

Price alert · HALO

All alert types
128.95 USD -1.96 -1.50%

At close · Nov 2

128.95 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
128.93 × 1
Ask
128.94 × 2
127.52 Day range 131.89
61.63 52-week range 131.18
YTD
+91.60%
1 year
+97.81%
Open
130.50
Prev close
130.91
Mkt cap
14.64B
Vol
3.36M
Avg vol
2.29M
EPS
3.42
P/E
37.70
Div yield
0.00%
More statistics
Low
127.52
High
131.89
Forward P/E
12.08
Beta
0.90
Short ratio
4.97
Inst. own
113.62%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
113.70
200-d avg
83.37
1y target
108.78

5D chart

Chart tools
Interval
1m5m15m30m

Signals (135)
NameTimeAgo
SMA: BearishNov 2, 3:55 PM11 hours ago
RSI: OverboughtNov 2, 3:35 PM11 hours ago
SMA: BullishNov 2, 3:00 PM11 hours ago
SMA: BullishNov 2, 2:55 PM12 hours ago
MACD: Buy SignalNov 2, 2:55 PM12 hours ago
SMA: BearishNov 2, 2:05 PM12 hours ago
SMA: BullishNov 2, 2:00 PM12 hours ago
MACD: Sell SignalNov 2, 1:40 PM13 hours ago
MACD: Buy SignalNov 2, 1:35 PM13 hours ago
MACD: Sell SignalNov 2, 1:30 PM13 hours ago
SMA: BearishNov 2, 1:15 PM13 hours ago
SMA: BearishNov 2, 1:15 PM13 hours ago
SMA: BullishNov 2, 1:10 PM13 hours ago
SMA: BearishNov 2, 12:55 PM14 hours ago
SMA: BullishNov 2, 12:50 PM14 hours ago
SMA: BullishNov 2, 12:50 PM14 hours ago
SMA: BearishNov 2, 12:30 PM14 hours ago
SMA: BearishNov 2, 12:30 PM14 hours ago
SMA: BullishNov 2, 12:15 PM14 hours ago
SMA: BullishNov 2, 12:05 PM14 hours ago

Newest 20 of 135.

Analyst view

Consensus: none

Price target (mean) 108.78 -15.6% downside
Target (low)
78.00
Target (mean)
108.78
Target (high)
130.00
Ratings (0m) 9 7 buy · 2 hold · 0 sell
  • Strong buy2
  • Buy5
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 9
  • 1 month ago 9
  • 2 months ago 9

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

HALO analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter2.352.33 – 2.371.72+36.7%490.85M+38.5%6
Next quarter2.622.46 – 2.75-0.24+1193.3%537.59M+19.0%6
Current year8.848.65 – 8.954.15+112.9%1.88B+34.7%6
Next year10.6810.11 – 11.278.84+20.8%2.10B+11.7%5

Upgrades and downgrades

The latest rating changes

HALO analyst upgrades and downgrades
DateFirmActionFromTo
Oct 13, 2026TD CowenMaintainedBuyBuy
Oct 8, 2026JP MorganMaintainedNeutralNeutral
Oct 8, 2026HC Wainwright & Co.MaintainedBuyBuy
Sep 2, 2026HC Wainwright & Co.ReiteratedBuyBuy
Aug 7, 2026Leerink PartnersUpgradeMarket PerformOutperform
Aug 7, 2026TD CowenMaintainedBuyBuy
Aug 7, 2026CitizensMaintainedMarket OutperformMarket Outperform
Aug 7, 2026Wells FargoMaintainedEqual-WeightEqual-Weight
Aug 7, 2026HC Wainwright & Co.MaintainedBuyBuy
Jul 21, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 12, 2026Morgan StanleyMaintainedOverweightOverweight
Apr 29, 2026HC Wainwright & Co.MaintainedBuyBuy
Feb 19, 2026BenchmarkMaintainedBuyBuy
Feb 19, 2026Wells FargoMaintainedEqual-WeightEqual-Weight
Jan 8, 2026TD CowenMaintainedBuyBuy
Dec 19, 2025HC Wainwright & Co.ReiteratedBuyBuy
Nov 28, 2025HC Wainwright & Co.ReiteratedBuyBuy
Nov 18, 2025Goldman SachsMaintainedNeutralNeutral
Nov 4, 2025CitizensMaintainedMarket OutperformMarket Outperform
Oct 27, 2025JP MorganMaintainedNeutralNeutral
Oct 20, 2025Morgan StanleyMaintainedOverweightOverweight
Oct 15, 2025HC Wainwright & Co.ReiteratedBuyBuy
Oct 14, 2025Leerink PartnersUpgradeUnderperformMarket Perform
Oct 2, 2025HC Wainwright & Co.MaintainedBuyBuy
Sep 24, 2025BenchmarkMaintainedBuyBuy
Sep 22, 2025HC Wainwright & Co.MaintainedBuyBuy
Aug 18, 2025Morgan StanleyMaintainedOverweightOverweight
Aug 7, 2025JP MorganMaintainedNeutralNeutral
Aug 6, 2025JMP SecuritiesMaintainedMarket OutperformMarket Outperform
Aug 6, 2025HC Wainwright & Co.MaintainedBuyBuy